CRP and dilated cardiomyopathy: A real-world study by Qi et al. showed that a related marker, the CRP-to-lymphocyte ratio (CLR), had strong predictive power for mortality in patients with dilated cardiomyopathy, with higher accuracy than traditional ratios like NLR and PLR (11).